- Home
- GSAT vs VCYT Comparison
GSAT vs VCYT Comparison
Compare GSAT & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSAT
- VCYT
- Stock Information
- Founded
- GSAT 2003
- VCYT 2006
- Country
- GSAT United States
- VCYT United States
- Employees
- GSAT N/A
- VCYT N/A
- Industry
- GSAT Telecommunications Equipment
- VCYT Medical Specialities
- Sector
- GSAT Consumer Discretionary
- VCYT Health Care
- Exchange
- GSAT Nasdaq
- VCYT Nasdaq
- Market Cap
- GSAT 3.4B
- VCYT 3.2B
- IPO Year
- GSAT 2006
- VCYT 2013
- Fundamental
- Price
- GSAT $1.88
- VCYT $40.58
- Analyst Decision
- GSAT Strong Buy
- VCYT Buy
- Analyst Count
- GSAT 1
- VCYT 7
- Target Price
- GSAT $5.00
- VCYT $39.86
- AVG Volume (30 Days)
- GSAT 14.0M
- VCYT 807.5K
- Earning Date
- GSAT 02-26-2025
- VCYT 02-20-2025
- Dividend Yield
- GSAT N/A
- VCYT N/A
- EPS Growth
- GSAT N/A
- VCYT N/A
- EPS
- GSAT N/A
- VCYT N/A
- Revenue
- GSAT $241,581,000.00
- VCYT $425,331,000.00
- Revenue This Year
- GSAT $13.67
- VCYT $25.25
- Revenue Next Year
- GSAT $8.07
- VCYT $10.05
- P/E Ratio
- GSAT N/A
- VCYT N/A
- Revenue Growth
- GSAT 13.58
- VCYT 23.95
- 52 Week Low
- GSAT $1.00
- VCYT $18.61
- 52 Week High
- GSAT $2.74
- VCYT $46.00
- Technical
- Relative Strength Index (RSI)
- GSAT 45.19
- VCYT 47.05
- Support Level
- GSAT $1.82
- VCYT $40.29
- Resistance Level
- GSAT $1.93
- VCYT $43.53
- Average True Range (ATR)
- GSAT 0.14
- VCYT 1.83
- MACD
- GSAT -0.04
- VCYT -0.17
- Stochastic Oscillator
- GSAT 16.36
- VCYT 30.12
About GSAT Globalstar Inc.
Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services are typically used by customers where existing terrestrial wireline and wireless communications networks are impaired or do not exist. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is an owner of satellite assets. The company generates the vast majority of its revenue within the United States.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.